INTRODUCTION {#sec1-1}
============

Biliary cysts are cystic malformations that may occur anywhere in the bile duct system. Based on the latest classification scheme, they include intra and extra hepatic biliary cysts as well as the presence of an abnormal pancreatobiliary junction. Previously, we distinguished five types of biliary cysts.[@ref1] Type I cysts are most common (50 to 85% of cases) and are characterized by cystic or fusiform dilation of the common bile duct. These can be further subcategorized in Type IA, type IB and type IC. Type II cysts are diverticula of the extrahepatic bile duct and represent 2% of cysts. Type- III cysts represent a group of cystic dilatations limited to the intraduodenal area of the distal common bile duct and are also subcategorized into type IIIA and type IIIB (1 to 5% of cysts). Type IV cysts (15 to 35% of cysts) are defined as multiple cysts that can have both intra and extrahepatic involvement (Type-IVA have both intra and extrahepatic involvement, type IVB have only extrahepatic cysts). Type-V cysts imply one or more intrahepatic dilatations. Prevalence rates show a marked female predominance, with a female to male ratio of 3:1.[@ref2] Most patients with biliary cysts will present in their childhood,[@ref3] by the age of 10 with only 20% of cases undiagnosed into adulthood. The clinical presentation most often consists of abdominal pain, palpable mass and jaundice.[@ref4] This clinical presentation is more typical for children than adults.[@ref5]

Biliary cysts complicated with cholangitis in pregnant women are an extremely rare condition.[@ref6] To the best of our knowledge, there are no large or relevant epidemiological studies that show the prevalence of biliary cysts in pregnant women, or the prevalence of cholangitis within this group of patients. There are only several case-series or case reports available in recent literature. However, such cases are considered highly life-threatening for both expectant mothers and the fetus.[@ref7] Until now, there was no unified proposed treatment strategy for the treatment of choledochal cysts with cholangitis during pregnancy. In the past five years, we have developed an effective method, which provides a safe and efficacious approach to this complex clinical situation. Our goal was to ensure the safety of the mother and child until the end of pregnancy, followed by a complete removal of the lesion of the common bile duct post-delivery.

METHODS {#sec1-2}
=======

Presentation of cases {#sec2-1}
---------------------

From January 2010 to January 2015, we identified six in-patients with choledochal cysts alongside cholangitis during pregnancy. The age of the patients ranged from 20 to 27 with gestational age from 20 to 32 weeks. The patients presented to hospital due to varying degrees of upper abdominal pain, fever or jaundice. All of them underwent abdominal ultrasound demonstrating cystic dilatation of the common bile duct and inflammation. Blood samples were also taken for laboratory analysis. As patients were highly susceptible, they were immediately admitted for further treatment and evaluation.

Treatment strategy {#sec2-2}
------------------

Upon admission, we conducted some routine medical tests including routine blood sampling, liver function test and electrolyte levels. Empirical antibiotic treatment was initiated as well as rapid fluid replacement. Considering the particularity of these cases, we consulted the help of the Department of Obstetrics and Gynecology at the time of admission. Based on the Tokyo guidelines for cholangitis,[@ref8] these six patients did not require emergency exploratory laparotomy. In order to ensure the safety of the expectant mother and fetus, we decided to treat them in stages. The first stage was percutaneous transhepatic gallbladder drainage (PTGBD) under ultrasound guidance and sustained negative pressure suction, which was maintained until delivery. The second staging was elective choledochal cyst excision after the patient recovered after delivery. The protocol and the consent form of this manuscript were approved by the institution's Human Research Committee of the Jilin University, China.

RESULTS {#sec1-3}
=======

First hospitalization {#sec2-3}
---------------------

The clinical data of six patients collected during their first hospitalization are summarized in [Table-I](#T1){ref-type="table"}. After antibiotic treatment and rapid fluid infusion was completed, only one patient underwent MRCP in addition to the ultrasound check up due to the possible risks for the fetus. All patients had PTGBD conducted using a 22 G puncture tube of the COOK company, and biliary drainage for three to five days. Every day, approximately 400ml of bile was drained, and the symptoms of acute inflammation gradually relieved. After the symptoms improved significantly, we clipped the drainage tube and discharged these patients from the hospital. After delivery and recovery, patients came back and had the definitive surgery for the choledochal cyst. Only one patient returned, two weeks after discharge, due to frequent vomiting. We maintained the electrolyte balance combined with rapid fluid infusion. After the treatment, the symptoms of the patient relieved.

###### 

First hospitalization information.

                                  *Patient I*                                           *Patient II*                                             *Patient III*                              *Patient IV*                            *Patient V*                             *Patient VI*
  ------------------------------- ----------------------------------------------------- -------------------------------------------------------- ------------------------------------------ --------------------------------------- --------------------------------------- --------------------------------------------------------
  Age (years)                     20                                                    23                                                       24                                         27                                      27                                      27
  Parity                          Primipara                                             Primipara                                                Multipara                                  Primipara                               Primipara                               Primipara
  Gestational weeks               28                                                    30                                                       20                                         32                                      22                                      26
  Clinical symptoms               Upper abdominal pain, jaundice, fever                 Upper abdominal pain, jaundice, fever                    Upper abdominal pain, jaundice, vomiting   Upper abdominal pain, fever, nausea     Upper abdominal pain, fever, vomiting   upper abdominal pain, jaundice, fever
  Leukocyte (×10^9^/L)            12.9                                                  14.5                                                     12.2                                       11.0                                    13.2                                    15.1
  Total bilirubin (umol/L)        240                                                   150                                                      120                                        10.1                                    26.3                                    100
  Ultrasound diagnosis            Not clear                                             Clear                                                    Clear                                      Clear                                   Clear                                   Clear
  Other imaging examination       MRCP                                                  None                                                     None                                       None                                    None                                    None
  Imaging reveal                  Cyst mass of common bile duct with internal density   Cystic dilatation of common and intrahepatic bile duct   Cystic dilatation of common bile duct      Cystic dilatation of common bile duct   Cystic dilatation of common bile duct   Cystic dilatation of common and intrahepatic bile duct
  Cholelithiasis                  Gallbladder and bile duct stones                      Bile duct stones                                         None                                       None                                    None                                    Gallbladder and bile duct stones
  Size of choledochal cyst (cm)   12×10                                                 15×5                                                     10×8                                       12×5                                    11×6                                    11×6
  PTGBD                           Successful                                            Successful                                               Successful                                 Successful                              Successful                              Successful

†***PTGBD*** percutaneous transhepatic gallbladder drainage

Second hospitalization {#sec2-4}
----------------------

The clinical data of the six patients collected during their second hospitalization are summarized in [Table-II](#T2){ref-type="table"}.

###### 

Second hospitalization information.

                                         *Patient I*                           *Patient II*                                                                  *Patient III*                         *Patient IV*                          *Patient V*                           *Patient VI*
  -------------------------------------- ------------------------------------- ----------------------------------------------------------------------------- ------------------------------------- ------------------------------------- ------------------------------------- -------------------------------------
  Admission date after delivery (days)   35                                    33                                                                            33                                    32                                    40                                    35
  Delivery mode                          Vaginal delivery                      Vaginal delivery                                                              Cesarean section                      Cesarean section                      Vaginal delivery                      Vaginal delivery
  Leukocyte (×10^9^/L)                   7.7                                   6.6                                                                           5.9                                   8.8                                   6.5                                   9.0
  Total bilirubin (umol/L)               24.5                                  15.4                                                                          17.9                                  13.5                                  12.2                                  12.8
  Imaging examination                    Ultrasound                            Ultrasound, MRCP                                                              Ultrasound, MRCP                      Ultrasound, MRCP                      Ultrasound, abdominal CT              Ultrasound, MRCP
  Type of cyst                           Type I                                Type IV                                                                       Type I                                Type I                                Type I                                Type IV
  Operation method                       Cyst resection, hepaticojejunostomy   Cyst resection, anastomosis between secondary hepatic bile duct and jejunum   Cyst resection, hepaticojejunostomy   Cyst resection, hepaticojejunostomy   Cyst resection, hepaticojejunostomy   laparoscopic cyst internal drainage
  Postoperative complications            Intraperitoneal infection             None                                                                          None                                  None                                  Much intraperitoneal drainage         None

Patients came back to our department after they delivered healthy babies one month later. All of the patients had no infection, no electrolyte disorder and bilirubin levels within normal range. However, all patients had mildly elevated liver enzymes. Patients were followed up with imaging tests, defining the classification of their biliary cysts and made pre-operative plans.

The prognosis and follow-up {#sec2-5}
---------------------------

There were no serious complications after drainage and during the perioperative period. We followed up all six patients six months to one year, and no serious complications were recorded. The immediate curative effect was excellent.

DISCUSSION {#sec1-4}
==========

The diagnostic rate of adult choledochal cyst accounts for only around 20% of cases in the literature. Even though large studies or systematic reviews regarding such patients are scarce, it is safe to conclude that choledochal cysts are rarely diagnosed during pregnancy. Biliary cysts represent a life-threatening diagnosis for both expectant mother and the fetus, when complicated with cholangitis. During pregnancy, the intra-abdominal pressure increases.[@ref9] This may disrupt the dynamic balance of the static choledochal cyst, resulting in some severe complications. Due to the pathophysiological processes involved, one of the most common underlying diseases is cholangitis. For a clinician, it is difficult to guarantee successful outcomes if the resection of lesions and bile duct is conducted in the first admission. Therefore, choosing a reasonable operation time and operative methods is the key to the success of the procedure.

In 1977, Todani[@ref10] classified choledochal cyst into five types. Most surgeons apply this classification clinically. The operative methodology has been explored in the last few decades. These have included open internal or external cyst drainage, Roux-en-Y hepaticojejunostomy, and liver transplantation for Caroli's disease.[@ref11]

Although the traditional operative technique is suitable for the mother, it inevitably has many adverse impacts on delivery and the fetus. According to some studies, surgery during pregnancy, increases significantly mortality and complication rates.

Other studies have demonstrated that laparotomy and internal or external drainage in the second trimester of pregnancy was relatively safe.[@ref12] Nevertheless, there have been reported cases resulting in premature delivery under surgical intervention. Based on the specificity of choledochal cysts with cholangitis during pregnancy, it is important to develop and explore a method which can ensure minimal trauma to both the expectant mother and fetus. Guided by the concept of minimally invasive treatment, we sought to devise a procedure that would control and cure the disease whilst reducing mortality and complications rates. In this study we have demonstrated a treatment by stages, instead of a traditional one-stage operation, aimed at improving operative outcomes.

After diagnosis has been made within 24 hours, we conducted PTGBD under ultrasound guidance and sustained negative pressure suction in our patients. Due to inflammation of the common bile duct, the pressure in the bile duct was higher than in the gallbladder. The bile wall was sucked by external negative pressure drainage device according to the pressure distribution. The reason why we opted for PTGBD instead of percutaneous transhepatic bile duct drainage (PTBD) or other choledochal cyst drainage is that PTGBD is more convenient for emergency treatment. Additionally, its functionality can also be easily restored if the tube becomes blocked or loose during drainage. Furthermore, the fetus is minimally endangered during PTGBD.

The symptoms of cholangitis can be relieved within 24 - 48 hours after drainage. We observed these patients for three to five days after the procedure, while maintaining the balance of electrolytes combined with rapid fluid infusion. When the patients were in stable condition, patients were discharged after the drainage tube was clipped.

Nearly one month after delivery, six patients came back to our department and completed examinations. Four of them had Type-I choledochal cysts, and underwent Roux-en-Y hepaticojejunostomy. The operations were successful and no unexpected events were reported. One patient was diagnosed with Type-IV choledochal cyst. We decided for an anastomosis between the secondary hepatic bile duct and jejunum using the Roux-en-Y method. Because of partial cyst excision, some intrahepatic biliary cysts remained. Due to personal reasons, another patient with Type-IV choledochal cyst refused an operation, so we conducted a laparoscopic cyst internal drainage.

After surgery, one patient with a larger cyst and a long operation time had a persistent low fever and right upper abdominal pain. We assumed that he may have an intraperitoneal infection, and after antimicrobial treatment the symptoms relieved. Another patient's cyst adhered to surrounding tissue tightly which resulted in intraoperative bleeding. The total volume of intraperitoneal drainage was increased. After conservative treatment, their condition improved. Those postoperative complications match to Grade II of Clavien-Dindo classification.[@ref13]

In recent years, minimally invasive treatment has become the forefront of treating conditions with minimal complications. Due to the possible severe complications[@ref14]-[@ref16] for expectant mothers and fetuses, it was unreasonable to conduct surgical resection and exploration immediately after the diagnosis has been made. Without a thoroughly conducted examination prior to the surgery it is difficult to create a detailed operation plan.

This study showed that PTGBD, under ultrasound guidance, could relieve the symptoms of cholangitis and have minimal impact on the delivery and fetus. At the same time, it reduced pressure in the bile duct and avoided severe complications such as ruptured cholangitis. After the relief of cholangitis, patients were able to return home for recovery with a clipped drainage tube. If the symptoms of cholangitis emerged again during the period of pregnancy, the patient could re-open the drainage tube. This convenience had a significant advantage over open or laparoscopic cyst drainage. Another benefit of this strategy was that doctors were able to diagnose the cyst type followed by an optimal surgical plan. It is possible that long-term biliary drainage interfered with bile metabolism, as the liver enzymes of the patients slightly increased. After the operation, two patients developed mild complications which were cured soon. We consider those complication completely unrelated to our treatment by stages.

CONCLUSIONS {#sec1-5}
===========

We can conclude that choledochal cysts with cholangitis during pregnancy are a complicated disease to treat. Our treatment by stages approach, presented in this study, represents a treatment with optimal efficacy and without severe complications.

Limitations of the Study {#sec2-6}
------------------------

There are some limitations of this study. It represents a case series of six patients which makes these results unsuitable for a definite conclusion. Larger studies that would support our approach are needed. Moreover, we should conduct more studies regarding the liver function, electrolyte imbalance and other pathophysiological processes present in these patients.
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